PET/CT Evaluation of Cardiac Sarcoidosis

PET Clin. 2019 Apr;14(2):223-232. doi: 10.1016/j.cpet.2018.12.004. Epub 2019 Feb 1.

Abstract

The increasing implementation of advanced cardiovascular imaging in the form of cardiac PET/CT has had a significant impact on the management of cardiac sarcoidosis, which continues to evolve. This review summarizes the role of PET/CT imaging in sarcoidosis with a specific focus on (1) indications, (2) patient preparation, (3) test performance, (4) study interpretation, (5) clinical relevance of findings, (6) comparison to alternative imaging modalities, and finally (7) introduction of areas of anticipated development and research.

Keywords: Cardiac sarcoidosis; Fluorine-18 deoxyglucose; Positron emission tomography.

Publication types

  • Review

MeSH terms

  • Biomedical Technology / trends
  • Cardiomyopathies / diagnostic imaging*
  • Fluorodeoxyglucose F18
  • Humans
  • Myocardial Perfusion Imaging / methods
  • Myocardial Perfusion Imaging / standards
  • Myocardial Perfusion Imaging / trends
  • Positron Emission Tomography Computed Tomography / methods*
  • Positron Emission Tomography Computed Tomography / standards
  • Positron Emission Tomography Computed Tomography / trends
  • Radiopharmaceuticals
  • Sarcoidosis / diagnostic imaging*
  • Sensitivity and Specificity
  • Tomography, Emission-Computed, Single-Photon / methods
  • Tomography, Emission-Computed, Single-Photon / standards
  • Tomography, Emission-Computed, Single-Photon / trends

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18